CERENO SCIENTIFIC AB B (F:4A1) — Stock Price
CERENO SCIENTIFIC AB B (F:4A1) is currently trading at €0.43 EUR, up 1.14% today. Over the past 52 weeks, shares have ranged between €0.39 and €0.91. This page tracks CERENO SCIENTIFIC AB B's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 4A1 market cap.
CERENO SCIENTIFIC AB B (4A1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CERENO SCIENTIFIC AB B's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
CERENO SCIENTIFIC AB B Income Statement — Revenue, Profit & Earnings by Year
CERENO SCIENTIFIC AB B's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Cost of Revenue | €-44.27 Million | €-80.90 Million | €-49.28 Million | €-57.54 Million | €-44.81 Million |
| Gross Profit | €44.27 Million | €80.90 Million | €49.28 Million | €57.54 Million | €44.81 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | €76.44 Million | €57.62 Million |
| Total Operating Expenses | €74.60 Million | €75.84 Million | €44.24 Million | €26.60 Million | €14.78 Million |
| Operating Income | €-74.60 Million | €-75.84 Million | €-44.24 Million | €-26.60 Million | €-14.78 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €44.55 Million | €26.09 Million | €5.30 Million | €459.07K | €1.25 Million |
| Income Before Tax | €-117.75 Million | €-99.53 Million | €-48.11 Million | €-27.65 Million | €-16.25 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-117.75 Million | €-99.53 Million | €-48.11 Million | €-27.65 Million | €-16.25 Million |
CERENO SCIENTIFIC AB B Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CERENO SCIENTIFIC AB B's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €402.67 Million | €413.77 Million | €284.99 Million | €215.65 Million | €180.74 Million |
| Total Current Assets | €78.35 Million | €133.00 Million | €88.70 Million | €68.63 Million | €91.24 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €150.20 Million | €221.85 Million | €68.56 Million | €14.14 Million | €10.67 Million |
| Total Current Liabilities | €25.20 Million | €31.45 Million | €23.16 Million | €13.74 Million | €10.27 Million |
| Long-term Debt | €125.00 Million | €190.40 Million | €45.40 Million | €400.00K | €400.00K |
| Net Debt | €50.36 Million | €62.82 Million | — | — | — |
| Total Stockholder Equity | €252.47 Million | €191.93 Million | €216.42 Million | €201.51 Million | €170.06 Million |
| Retained Earnings | — | — | — | €-57.97 Million | €-30.22 Million |
CERENO SCIENTIFIC AB B Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CERENO SCIENTIFIC AB B generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-111.86 Million | €-103.42 Million | €-36.92 Million | €-18.62 Million | €-13.14 Million |
| Capital Expenditures | €44.34 Million | €84.77 Million | €49.28 Million | €57.54 Million | €44.81 Million |
| Free Cash Flow | €-156.21 Million | €-188.20 Million | €-86.19 Million | €-76.15 Million | €-57.94 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | €1.42 Million | €1.67 Million | — | — |
| Depreciation | €787.89K | €286.94K | €14.31K | €14.31K | €14.31K |
| Change in Cash | €-52.94 Million | €40.41 Million | €20.12 Million | €-22.59 Million | €23.63 Million |
CERENO SCIENTIFIC AB B Earnings History — EPS Actual vs. Analyst Estimates
Track CERENO SCIENTIFIC AB B's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 27, 2026 | — | — | — |
| Feb 27, 2026 | — | — | — |
| Nov 27, 2025 | — | — | — |
| Aug 27, 2025 | — | — | — |
| May 22, 2025 | — | — | — |